Karolinska Institutet is one of the world’s leading medical universities. Our vision is to advance knowledge about life and strive towards better health for all. Karolinska Institutet accounts for the single largest share of all academic medical research conducted in Sweden and offers the country’s broadest range of education in medicine and health sciences. The Nobel Assembly at Karolinska Institutet selects the Nobel laureates in Physiology or Medicine.
The Press Office at Karolinska Institutet handles inquiries from the media about press images and contact information to our university management, scientists, and other experts. The press phone is staffed from 9 am to 7 pm CET on weekdays, and from 9 am to 5 pm CET on weekends (outside office hours only for urgent requests). On Swedish public holidays we are closed. Emails are answered during office hours.
Phone: +46(0)8-524 860 77 Â | Â Email: pressinfo@ki.se
Further contact information, images and links can be found in our online pressroom
For more news from Karolinska Institutet, please go to KI News
Conferment ceremony, Stockholm City Hall, May 2014. Credit: Ulf Sirborn.
Address:
SE-171 77 Stockholm
Phone:
+46 (0)8-52480000
Head of public authority (President/Vice-Chancellor/CEO/DG):
President Annika Ă–stman Wernerson
URL:
Name:
Phone:
+46 (0)8-524 860 77
Mobile phone:
office phone is redirected
28 February, 2023 - Karolinska Institutet
Following a successful pilot study, an online anonymous treatment program aimed at reducing child sexual abuse by providing treatment to individuals who exhibit sexual urges towards children is being launched across the EU. It is now available in Swedish, German, and Portuguese as well as in an updated English version. The treatment program, which has […]
29 April, 2021 - Karolinska Institutet
Researchers at Karolinska Institutet and the Public Health Agency of Sweden have studied newborn babies whose mothers tested positive for SARS-CoV-2 during pregnancy or childbirth. The results show that although babies born of test-positive mothers are more likely to be born early, extremely few were infected with COVID-19. The study, which is published in the […]
27 April, 2020 - Karolinska Institutet
Only about five per cent of the babies born to mothers with hepatitis C are themselves infected by the disease. A possible reason for this low figure is that the baby’s immune system has already destroyed the virus before birth. A new study from researchers at KI and published in the journal Gut reveals clear […]
7 April, 2020 - Karolinska Institutet
People with celiac disease have increased risk of dying prematurely, despite increased awareness of the disease in recent years and better access to gluten-free food. This is according to a new study from Karolinska Institutet in Sweden and Columbia University in the U.S. published in the prestigious journal JAMA. Celiac disease was linked to increased […]
20 August, 2019 - Karolinska Institutet
Cytokines are a type of proteins that are important to the signaling between cells in the body’s immune system, for example in the case of an infection or injury. A new study which is being published in the Journal of Allergy and Clinical Immunology is now indicating that the cytokine interleukin(IL)-26 could be used as a biological marker (biomarker) for uncontrolled asthma in both adults and children – and could perhaps also be a future goal for new drugs against asthma. These results are presented by researchers at Karolinska Institutet and Lund University.
20 August, 2019 - Karolinska Institutet
Fat-soluble statins can prevent liver cancer and reduce mortality in patients with chronic viral hepatitis. These are findings from a study conducted by researchers at Karolinska Institutet in Sweden, among others. The study is published in Annals of Internal Medicine.
19 August, 2019 - Karolinska Institutet
Children with Inflammatory Bowel Disease (IBD) run a greater risk of psychiatric disorders, according to a new study from Karolinska Institutet in Sweden published in JAMA Pediatrics. The researchers claim that more psychological support and longer follow-up is needed for the children affected and their parents.
16 August, 2019 - Karolinska Institutet
The hormone secreting part of the pancreas, the islets of Langerhans, has a unique cyto-architecture that allows functional interrelationships between the different cell types. Somatostatin is secreted by the delta cell and is an effective inhibitor of the insulin secreting beta cell and the glucagon secreting alpha cell. According to a novel study from Sweden’s Karolinska Instiutet, published in the journal Nature Communications, the delta cell can thereby indirectly affect glucose homeostasis in health and disease.
16 August, 2019 - Karolinska Institutet
Researchers at Sweden’s Karolinska Institutet have discovered a new sensory organ that is able to detect painful mechanical damage, such as pricks and impacts. The discovery is being published in the scientific journal Science.
8 August, 2019 - Karolinska Institutet
Researchers at Karolinska Institutet in Sweden have investigated the long-term effect of hormonal therapy in women with the most common types of hormone-sensitive breast cancer. The results, presented in the journal JAMA Oncology, show that the treatment has a protective effect against distant metastatic cancer for both so-called Luminal A and Luminal B breast cancer subtypes, and a long-term effect for women diagnosed with Luminal A cancer.
Expertsvar, The Swedish Research Council, Hantverkargatan 11B, Stockholm SWEDEN, Phone +46(0)8 546 44 000
P.O. Box 1035, SE-101 38 Stockholm, expertsvar@vr.se
Information about cookies will open in a new window
